Studies on lymphokine production in lepromatous leprosy patients.
In order to evaluate whether lymphokine (LK) release is impaired in patients with lepromatous leprosy (LL), the production of two LKs, namely leukocyte inhibitory factor (LIF) and interleukin-2 (IL-2) from peripheral blood mononuclear cells of LL individuals was investigated. Results show that in eight patients CD4+ cells exhibit a reduced release of LIF, while CD8+ lymphocytes are still able to secrete this LK. In the remaining three patients both CD4+ and CD8+ cells produced LIF as do normal lymphocyte subpopulations. As far as IL-2 release is concerned, all patients fail to produce the above LK either using purified CD4+ or CD8+ lymphocytes. These data emphasize additional defects in immune responsiveness in leprosy.
Munno
I
I
Cattedra di Immunologia, Università di Bari, Facoltà di Medicina, Italy.
Pellegrino
N M
NM
Fumo
G
G
Barbieri
G
G
Jirillo
E
E
D000328:Adult; D015496:CD4-Positive T-Lymphocytes / Q000378:metabolism; D006801:Humans; D007376:Interleukin-2 / Q000096:biosynthesis*; D015440:Leprosy, Lepromatous / Q000276:immunology*; D008222:Lymphokines / Q000096:biosynthesis*; D008875:Middle Aged; D013601:T-Lymphocytes / Q000378:metabolism*; D050378:T-Lymphocytes, Regulatory / Q000378:metabolism
D007376:Interleukin-2; D008222:Lymphokines; C010598:leukocyte inhibitory factor